POLYPOIDAL CHOROIDAL VASCULOPATHY
Clinical trials for POLYPOIDAL CHOROIDAL VASCULOPATHY explained in plain language.
Never miss a new study
Get alerted when new POLYPOIDAL CHOROIDAL VASCULOPATHY trials appear
Sign up with your email to follow new studies for POLYPOIDAL CHOROIDAL VASCULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for blinding eye condition
Disease control CompletedThis study tested two treatments for polypoidal choroidal vasculopathy (PCV), an eye disease that can lead to blindness. Sixty patients received either eye injections of aflibercept alone or aflibercept combined with a special light therapy (reduced-fluence PDT). The goal was to …
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Phase: NA • Sponsor: Singapore National Eye Centre • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Eye disease study tracks 5-Year outcomes and recurrence risks
Knowledge-focused CompletedThis study followed 72 people with polypoidal choroidal vasculopathy (PCV), an eye condition that can cause vision loss, for 5 years after their first treatment. Researchers wanted to see how often the disease comes back, what treatments were needed, and if early treatment succes…
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC